April 7, 2008 : Genopsys Engages New Interim CEO
Genopsys, Inc. has announced the engagement of Larimore Cummins, M.D. as its interim CEO...

October 15 , 2006: Genopsys Patent Claims Accepted
Genopsys, Inc. has announced that the most significant claims of its latest patent application have been accepted by the US Patent office...

August 01, 2006: Genopsys Enters into Agreement with AdapCS, Inc.
Genopsys, Inc. has announced that it has entered into an operating agreement with AdapCS, Inc. of Marina, CA...

February 17, 2005: Genopsys Achieves Milestone
Methods demonstrated to improve beta-lactamase stability, a key step towards introduction of a molecular platform with the potential for both diagnostic and therapeutic protein pharmaceuticals...

January 05, 2005: Genopsys Opens New Lab
Genopsys, Inc., a privately held biotechnology company developing proprietary diversity technologies to rapidly optimize novel protein products, recently moved into new facilities in Soquel, CA...

August 15, 2004: Genopsys Receives SBIR Phase II Funding from the NIH
Genopsys, Inc. today announced that the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), has awarded the company a grant for the discovery and development of enzymes to detect several molecular markers for cancer...

October 7, 2003: Genopsys Secures Antibody Engineering Patent
Genopsys, Inc. today announced that the company has been issued a new patent that is directed to the optimization of binding affinity, binding specificity, stability, and other critical characteristics associated with antibodies or antibody-like proteins in research, diagnostics, and therapeutic applications...